Trajectory of weight change after discontinuation of AOMs Overall Overall, compared with control groups, AOM treatment was significantly associated with greater weight regain which varied according to follow-up time point after treatment discontinuation (Fig
A second collagenase injection was administered three days later

Key points: GLP-1s (glucagon-like peptide-1 receptor agonists) support type 2 diabetes by reducing appetite and supporting weight loss alongside their effects on the pancreas GLP-1-assisted programmes lead to a clinically significant weight loss of 10% or more, which can significantly reduce complications associated with obesity Combining semaglutide with lifestyle interventions leads to significantly more weight loss than lifestyle interventions alone, with 87% of participants losing more than 10% of their body weight Semaglutide is more effective at supporting weight loss than liraglutide Tirzepatide is more effective than semaglutide at reducing weight, with all three doses of tirzepatide leading to more significant weight loss than 1mg of semaglutide The higher doses of tirzepatide (10mg and 15mg) might reduce weight by 5.15kg more than 2mg of semaglutide, while there appears to be no difference between 5mg of tirzepatide and 2mg of semaglutide 3) Side effects and safety All medications have possible side effects, particularly if you live with other health conditions

The decision framework should prioritize individual health status, specific therapeutic goals, and risk tolerance
It has a composition based on natural ingredients and is completely safe for the body
On the basis of liraglutide, more than 40 candidates were screened again, and finally semaglutide was finally obtained